Affiliation:
1. Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, Sienkiewiczova 1, 81371 Bratislava, Slovakia
2. Institute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 9 Dubravska cesta, 84104 Bratislava, Slovakia
Abstract
Cardiometabolic diseases (CMDs) encompass a range of prevalent, often preventable, non-communicable illnesses, including myocardial infarction, stroke, cardiac insufficiency, arterial hypertension, obesity, type 2 diabetes mellitus, insulin resistance, chronic renal dysfunction, non-alcoholic fatty liver disease, and rare metabolic disorders [...]
Funder
Slovak Research and Development Agency
Ministry of Education, Science, Research and Sport of the Slovak Republic
Reference40 articles.
1. Lifestyle or pharmacotherapy in cardio-metabolic disease prevention;Seidu;Ther. Adv. Cardiovasc. Dis.,2023
2. Update on the obesity epidemic: After the sudden rise, is the upward trajectory beginning to flatten?;Koliaki;Curr. Obes. Rep.,2023
3. Prevalence and factors associated with overweight and obesity in Kenya;Mkuu;Prev. Med. Rep.,2021
4. Recent origin and evolution of obesity-income correlation across the United States;Bentley;Palgrave Commun.,2018
5. NCD Risk Factor Collaboration (NCD-RisC) (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet, 398, 957–980.